1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Θετικών Επιστημών
  4. Τμήμα Χημείας
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/8870
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTsoukatos, D. C.en
dc.contributor.authorBrocheriou, I.en
dc.contributor.authorMoussis, V.en
dc.contributor.authorPanopoulou, C. P.en
dc.contributor.authorChristofidou, E. D.en
dc.contributor.authorKoussissis, S.en
dc.contributor.authorSismanidis, S.en
dc.contributor.authorNinio, E.en
dc.contributor.authorSiminelakis, S.en
dc.date.accessioned2015-11-24T16:45:01Z-
dc.date.available2015-11-24T16:45:01Z-
dc.identifier.issn0022-2275-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8870-
dc.rightsDefault Licence-
dc.subjectatherosclerosisen
dc.subjectmacrophagesen
dc.subjectsmooth muscle cellsen
dc.subjectlipoproteinsen
dc.subjectatherogenesisen
dc.subjectoxidized ldlen
dc.subjectmacrophagesen
dc.subjectlow-density-lipoproteinen
dc.subjectphospholipase a(2) isoformsen
dc.subjecthuman-plasmaen
dc.subjectatherosclerotic lesionsen
dc.subjectpaf-acetylhydrolaseen
dc.subjectfactor receptoren
dc.subjectldlen
dc.subjectexpressionen
dc.subjectoxidationen
dc.subjectphosphatidylcholinesen
dc.titlePlatelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary arteryen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDOI 10.1194/jlr.M800188-JLR200-
heal.identifier.secondary<Go to ISI>://000259201300018-
heal.identifier.secondaryhttp://www.jlr.org/content/49/10/2240.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2008-
heal.abstractPlatelet-activating factor (PAF), the potent phospholipid mediator of inflammation, is involved in atherosclerosis. Platelet-activating factor-acetylhydrolase (PAF-AH), the enzyme that inactivates PAF bioactivity, possesses both acetylhydrolase and transacetylase activities. In the present study, we measured acetylhydrolase and transacetylase activities in human atherogenic aorta and nonatherogenic mammary arteries. Immunohistochemistry analysis showed PAF-AH expression in the intima and the media of the aorta and in the media of mammary arteries. Acetylhydrolase and transacetylase activities were (mean +/- SE, n = 38): acetylhydrolase of aorta, 2.8 +/- 0.5 pmol/min/mg of tissue; transacetylase of aorta, 3.3 +/- 0.7 pmol/min/mg of tissue; acetylhydrolase of mammary artery, 1.4 +/- 0.3 pmol/min/mg of tissue (P < 0.004 as compared with acetylhydrolase of aorta); transacetylase of mammary artery, 0.8 +/- 0.2 pmol/min/mg of tissue (P < 0.03 as compared with acetylhydrolase of mammary artery). Lyso-PAF accumulation and an increase in PAF bioactivity were observed in the aorta of some patients. Reverse-phase HPLC and electrospray ionization mass spectrometry analysis revealed that 1-O-hexadecyl-2 acetyl-sn glycero-3-phosphocholine accounted for 60% of the PAF bioactivity and 1-O-hexadecyl-2-butanoyl-sn-glycerol-3-phosphocholine for 40% of the PAF bioactivity. The nonatherogenic properties of mammary arteries may in part be due to low PAF formation regulated by PAF-AH activity. In atherogenic aortas, an imbalance between PAF-AH and transacetylase activity, as well as lyso-PAF accumulation, may lead to unregulated PAF formation and to progression of atherosclerosis.en
heal.journalNameJournal of Lipid Researchen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Show simple item record
Files in This Item:
File Description SizeFormat 
Tsoukatos-2008-Platelet-activating.pdf399.97 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons